Back
Compugen 10K Form
Sell
24
CGEN
Compugen
Last Price:
1.65
Seasonality Move:
24.15%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CGEN News And Ratings
See the #1 stock for the next 7 days that we like better than CGEN
CGEN Financial Statistics
Sales & Book Value
| Annual Sales: | $33.46M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.65 |
| Price / Book: | 2.52 |
Profitability
| EPS (TTM): | -0.09000 |
|---|---|
| Net Income (TTM): | $-9.53M |
| Gross Margin: | $31.46M |
| Return on Equity: | -15.95% |
| Return on Assets: | -9.73% |
Compugen Earnings Forecast
Key Compugen Financial Ratios
- The Gross Profit Margin over the past 25 years for CGEN is 94.01%.
- The Selling, General & Administrative Expenses for CGEN have been equal to 29.81% of Gross Profit Margin.
- The Research & Development expenses have been 103.03% of Revenue.
- The Interest Expense is -0.09% of Operating Income.
- The Net Earning history of CGEN is -56.05% of Total Revenues.
- Per Share Earnings over the last 25 years have been positive in 12 years.
Compugen Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CGEN |
| CUSIP: | M25722 |
| Website: | cgen.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.12 |
| Quick Ratio: | 4.11 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |